Mirati Therapeutics (MRTX) Board Elects Shalini Sharp as New Independent Director

Mirati Therapeutics, Inc. (NASDAQ: MRTX), a late-stage targeted oncology company, today announced its Board of Directors has elected a new independent director, Ms. Shalini Sharp.

"I am pleased to welcome Shalini to our Board during a transformative time for the company," said Faheem Hasnain, chairman of the board, Mirati Therapeutics, Inc. "She brings strong strategic leadership experience, and breadth of expertise in the life sciences industry and financial management. I look forward to having her perspective on the board to help the company advance its mission for patients with cancer."

Ms. Sharp has more than 25 years of financial and corporate strategy experience in the life sciences industry. Most recently, she was the Chief Financial Officer (CFO) at Ultragenyx where she was responsible for leading the company's corporate finance, strategy, and information technology functions. Prior to Ultragenyx, Ms. Sharp was CFO at Agenus Inc., and before that, she worked in corporate strategy at Elan Pharmaceuticals, management consulting at McKinsey & Company, and investment banking at Goldman Sachs, in the pharmaceutical and medical device space. Ms. Sharp also serves as a board member of Neurocrine Biosciences, Precision Biosciences, Sutro Biopharma and TB Alliance. She previously served on the boards of Array BioPharma, Panacea Acquisition Corporation and Agenus. Ms. Sharp received a B.A. from Harvard College and an M.B.A. from Harvard Business School.

Ms. Sharp commented, "I am delighted to join the Board of Mirati Therapeutics, with its potential to deliver meaningful breakthrough therapies to patients fighting cancer. The company's exceptional research and development capabilities have generated a pipeline spanning the early to late-stage in important target areas, and I welcome the opportunity to play a role in helping the company at this pivotal point in its history as it approaches commercialization."

For more information about the Mirati Board of Directors, click here.

You May Also Be Interested In

• 22nd Century Group (XXII) Announces Resignation of Sullivan and Mish from Board
• DoorDash (DASH) Appoints Jeffrey Blackburn to its Board
• Snail (SNAL) Announces Resignation of Chief Strategy Officer and Chairman